Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies

This publication has 27 references indexed in Scilit:

• Canine Lymphomas
  Veterinary Pathology, 2013
• A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma
  The Veterinary Journal, 2012
• Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases
  Veterinary and Comparative Oncology, 2010
• Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma
  Journal of the American Veterinary Medical Association, 2010
• Serum C-Reactive Protein Concentration as an Indicator of Remission Status in Dogs with Multicentric Lymphoma
  Journal of Veterinary Internal Medicine, 2007
• Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy
  Journal of the American Veterinary Medical Association, 2007
• Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs
  Journal of Veterinary Internal Medicine, 1999
• Plasma Thymidine Kinase Activity in Dogs with Lymphoma and Leukemia.
  Journal of Veterinary Medical Science, 1997
• Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications
  Annals of Hematology, 1992
• Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans
  International Journal of Cancer, 1984